Application Notes & Case Studies

  1. Integrated Drug Discovery: Hit To PCC In 16 Months 5/8/2026

    Accelerate your drug discovery program with integrated, cross-functional expertise that advances promising candidates from hit identification to preclinical development with speed and efficiency.

  2. How A Global Biosimilars Company Cut Manual Data Errors By 50% 5/8/2026

    Learn how a global biopharmaceutical leader halved transcription errors and integrated over 350 instruments to accelerate the development of high-quality, clinically proven biosimilars.

  3. From 51% Yield To 87% With Targeted Impurity Removal 5/7/2026

    Targeted impurity identification and purification redesign dramatically improved yield, reduced process complexity, and enabled reliable API supply for Phase II clinical development.

  4. Overcoming Product Instability And Improving Yield 5/7/2026

    Early identification of hidden product instability enabled rapid process adjustments, improving yield and keeping a preclinical toxicology program on track despite challenging reaction conditions.

  5. Producing Quality APIs At Scale 5/7/2026

    Targeted process optimization transformed an early‑phase API with yield and impurity challenges into a scalable, high‑quality manufacturing process ready to support ongoing drug development.

  6. Predicting Performance Of Lotions Through Rheological Characterization 5/6/2026

    Rheological testing shows how small formulation differences influence spreading, flow, and feel during use. With minimal sample volumes, these methods connect lab measurements to real‑world performance.

  7. Rheology Is An Accurate Predictor Of Pharmaceutical Lotion Stability 5/6/2026

    Rheological creep testing provides a rapid way to predict pharmaceutical lotion stability by linking steady-state viscosity to particle settling behavior, enabling reliable shelf-life estimates.

  8. Rapid Selection Of High-Performance CHO Basal And Feed Media 5/5/2026

    A CHO-S bispecific antibody program needed a better basal and feed media combination. Learn how the screening of 180 conditions in 12 weeks identified one that delivered 38% higher titers.

  9. Successful Tech Transfer Meets Commercial Needs 5/5/2026

    An accelerated technology transfer reduced time to PPQ by over 25%, overcoming novel raw materials, unique IP constraints, and late‑stage process optimization to meet urgent commercial demand.

  10. Formulation & Delivery Of Spray Dried Biologics For Nasal Dosage Forms 4/27/2026

    Spray drying enables stable, scalable dry‑powder nasal biologics, improving shelf life, particle control, and targeted delivery for peptides, proteins, vaccines, and oligonucleotides.